Tickers

1. Composite Trajectory Verdict

The cash flow statement matters most for KNTK because its midstream asset base generates high non-cash depreciation and equity-method earnings, making operating cash flow the primary indicator of capacity to service debt and fund distributions.

Composite Trajectory: Mixed

The annual income statement shows revenue growth but operating income decline, with net income distorted by a large one-time gain; the annual cash flow statement shows a modest decline in operating cash flow; the annual balance sheet shows improved liquidity but higher leverage. The quarterly (six-month) income statement shows improving operating income and adjusted EBITDA, the cash flow statement shows higher operating cash flow but a sharp shift to negative financing cash flow due to dividend payments, and the balance sheet shows rising debt and declining liquidity. These cross-currents produce a mixed trajectory.

2. Red Flags

• GAAP net income jumped 115% to $525.9M in 2025 driven by a $415.4M gain on sale of EPIC, while operating income fell 8% to $164.9M (10-K 2025-12-31, Consolidated Statements of Operations).
• Operating cash flow declined 5% to $604.1M in 2025 despite a 19% revenue increase, reflecting a $302.9M decrease in non-cash adjustments including the large gain on sale (10-K 2025-12-31, Consolidated Statements of Cash Flows).
• Redeemable noncontrolling interest (Class C units) fell from $5.96B to $3.50B in 2025, a $2.46B reduction that materially changed the capital structure (10-K 2025-12-31, Consolidated Balance Sheets).
• The A/R Facility was fully drawn at $225M with zero availability as of June 30, 2026, after the facility limit was reduced from $250M (10-Q 2026-06-30, Liquidity table).
• Service revenue declined 25% year-over-year for the six months ended June 30, 2026, while product revenue grew 29%, increasing commodity price sensitivity (10-Q 2026-06-30, Results of Operations).
• Cash dividends of $263.1M paid in the first six months of 2026 exceeded the $341.5M operating cash flow after accounting for $192.3M capital expenditures, implying reliance on borrowings to fund distributions (10-Q 2026-06-30, Cash Flow and Liquidity sections).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP results for 2025 versus 2024 show total revenue up 19% to $1.76B, but operating income fell 8% to $164.9M as cost of sales rose 27% and operating expenses rose 38%. Net income including noncontrolling interest rose 115% to $525.9M, almost entirely due to a $415.4M gain on the EPIC sale versus an $89.8M gain on the GCX sale in 2024. Adjusted EBITDA (non-GAAP) increased 2% to $987.7M. For the six months ended June 30, 2026 versus 2025, total revenue rose 14% to $991.4M, operating income rose 35% to $130.1M, and net income including noncontrolling interest rose 26% to $118.0M. Adjusted EBITDA (non-GAAP) rose 8% to $532.0M. The annual trend shows margin compression in core operations, while the interim trend shows improving operating profitability.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow decreased 5% to $604.1M in 2025 from $637.3M in 2024, despite higher net income, because of a $302.9M reduction in non-cash adjustments (primarily the larger gain on sale) and a $44.0M decrease in distributions from unconsolidated affiliates. For the six months ended June 30, 2026, operating cash flow increased 12% to $341.5M from $305.9M in the prior year, driven by higher net income and non-cash adjustments. However, financing cash flow swung from a $92.8M inflow in the first half of 2025 to a $133.4M outflow in the first half of 2026, as the company paid $263.1M in dividends without offsetting debt proceeds. Investing cash outflows fell to $204.2M from $391.6M due to the absence of acquisition spending.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

At December 31, 2025 versus 2024, total assets rose 4% to $7.10B, total liabilities rose 8.6% to $4.17B, and long-term debt increased 8% to $3.63B. Liquidity (available borrowing capacity plus cash) more than doubled to $1.22B from $660.8M, aided by the new $1.15B term loan and $1.60B revolver. Redeemable noncontrolling interest fell 41% to $3.50B from $5.96B. At June 30, 2026 versus December 31, 2025, total assets rose 1.5% to $7.20B, total liabilities rose 3% to $4.29B, and long-term debt rose 2% to $3.70B. Liquidity declined to $1.07B from $1.22B, and the A/R Facility became fully utilized with no remaining capacity. The annual period shows strengthened liquidity but higher leverage; the interim period shows rising leverage and tightening liquidity.

6. Data Gaps

• Quarterly GAAP operating income by segment for Q2 2026 and Q2 2025 (only segment adjusted EBITDA provided in 10-Q).
• Full balance sheet detail for June 30, 2026 (the provided XBRL excerpt cuts off at commitments and contingencies).
• Standalone Q2 2026 quarter figures (only three-month and six-month aggregates provided; Q1 2026 10-Q not included in the document set).
• Debt maturity schedule beyond the revolving credit facility maturity (2030) and term loan maturity (2028).
• Free cash flow after maintenance capex (the filings disclose total capex but not maintenance vs. growth split).
• Comparative annual data prior to 2024 (2023 figures appear in the income statement but not in the balance sheet or cash flow statement in the provided excerpts).